Angelo Pirozzi: CAR-T cells targeting claudin18.2 in pretreated advanced PDAC by Changsong Qi et al.

Angelo Pirozzi, Medical Oncology Fellow at Humanitas University and Research Fellow at Mayo Clinic (Phoenix), made the following post on X:

”CAR-T cells targeting claudin-18.2 in pretreated advanced PDAC.

• 2 phase I/Ib trials with 24 patients.
• 79% ≥2 previous systemic lines.
• ORR 16.7%.
• DCR 70.8%.
• mPFS 3.3 months.
• mOS 10.0 months.
• mDoR 9.5 months.”

Read further.
Source: Angelo Pirozzi/X